Published in Gene Therapy Weekly, March 26th, 2009
"Results from our study show that ablating Ikbkap leads to embryonic lethality, with no homozygous Ikbkap knockout (Ikbkap(-/-)) embryos surviving beyond 12.5 days postcoitum. Morphological analyses of the Ikbkap(-/-) conceptus at different stages revealed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.